SCHEMBL30743002

SCHEMBL30743002

COC(=O)[C@@H]1[C@H](O[Si](c2ccccc2)(c2ccccc2)C(C)(C)C)CCCN1C(=O)OC(C)(C)C

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KLK7 P49862 1/20 0.43
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
KLK5 Q9Y337 1/20 0.39
HCRTR2 O43614 1/20 0.39
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
UCHL1 P09936 2/20 0.38
OPRD1 P41143 1/20 0.38
RIPK1 Q13546 1/20 0.37
USP30 Q70CQ3 2/20 0.37
GPR119 Q8TDV5 1/20 0.37
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30064881 0.94 KLK7 (0.38) KLK7MEN1KMT2ANPC1KLK5
SCHEMBL6052900 0.94 KLK7 (0.38) KLK7MEN1KMT2ANPC1KLK5
SCHEMBL6052905 0.94 KLK7 (0.38) KLK7MEN1KMT2ANPC1KLK5
SCHEMBL27043967 0.94 KLK7 (0.38) KLK7MEN1KMT2ANPC1KLK5
SCHEMBL4378972 0.94 KLK7 (0.38) KLK7MEN1KMT2ANPC1KLK5
SCHEMBL31759044 0.85 ALDH1A1 (0.38) MEN1KMT2AHCRTR2LMNAALDH1A1
SCHEMBL29889644 0.84 GPR119 (0.40) KLK7MEN1KMT2ALMNAALDH1A1
SCHEMBL22555052 0.84 GPR119 (0.40) KLK7MEN1KMT2ALMNAALDH1A1
SCHEMBL29889647 0.83 GPR119 (0.40) KLK7MEN1KMT2ANPC1LMNA
SCHEMBL29889630 0.83 KMT2A (0.36) KMT2ANPC1ALDH1A1NPSR1RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551577-A1 FUSED RING KRAS INHIBITORS FOR TREATING DISEASE Blossomhill Therapeutics, Inc. (US) 2025-05-14 EP disclosed
CN-119790058-A Fused cyclic KRAS inhibitors for the treatment of diseases 荣山医药股份有限公司 2025-04-08 CN disclosed
WO-2024015262-A1 FUSED RING KRAS INHIBITORS FOR TREATING DISEASE BLOSSOMHILL THERAPEUTICS, INC. (US) 2024-01-18 WO disclosed